Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
7.10
-0.23 (-3.14%)
Jun 27, 2025, 4:00 PM - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $808.93 million as of June 27, 2025. Its market cap has decreased by -4.08% in one year.
Market Cap
808.93M
Enterprise Value
580.36M
1-Year Change
-4.08%
Ranking
Category
Stock Price
$7.10
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $808.93M, an increase of 550.94%. That is a compound annual growth rate of 45.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 808.93M | -6.11% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 715.31B |
| Johnson & Johnson | 367.62B |
| AbbVie | 333.23B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 276.77B |
| Abbott Laboratories | 234.63B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |